I agree that this site is using cookies. You can find further informations here.
X
Wormser, David
98  results:
Search for persons X
?
1

Generating real-world data from health records: design of a..:

Hanson, Gillian ; Chitnis, Tanuja ; Williams, Mitzi J...
JAMIA Open.  5 (2022)  1 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
2

Risk of requiring a wheelchair in primary progressive multi..:

Butzkueven, Helmut ; Spelman, Tim ; Horakova, Dana...
European Journal of Neurology.  29 (2021)  4 - p. 1082-1090 , 2021
Link: https://doi.org/10.1111/..
 
?
3

Safety of Ocrelizumab in Multiple Sclerosis: Updated Analys..:

Alroughani, Raed ; Hauser, Stephen L. ; Kappos, Ludwig...
Multiple Sclerosis and Related Disorders.  37 (2020)  - p. 101589 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Design of a non-interventional post-marketing study to asse..:

Dirks, Petra ; Zingler, Vera ; Leemhuis, Jost...
BMC Neurology.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
5

Comorbid disease burden among MS patients 1968–2012: A Swed..:

Smith, Kelsi A ; Burkill, Sarah ; Hiyoshi, Ayako...
Multiple Sclerosis Journal.  27 (2020)  2 - p. 268-280 , 2020
Link: https://doi.org/10.1177/..
 
?
6

Safety of Ocrelizumab in Multiple Sclerosis: Updated Analys..:

Hauser, Stephen L. ; Kappos, Ludwig ; Montalban, Xavier...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
7

VERISMO: A Post-Marketing Safety Study to Determine the Inc..:

Wormser, David ; Evershed, Joanna ; Ferreira, Germano...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
8

Design of a Multi-Source Post-Marketing Study to Evaluate P..:

Margulis, Andrea ; Andrews, Elizabeth ; Hernandez-Diaz, Sonia...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
9

Safety of Ocrelizumab in Multiple Sclerosis: Updated Analys..:

Hauser, Stephen ; Kappos, Ludwig ; Montalban, Xavier...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
10

Design of the Ocrelizumab Pregnancy Registry to Assess Mate..:

Wormser, David ; Engel, Pierre ; Hahn, Kristen...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
11

Evaluating the Safety of Medication Exposures During Pregna..:

Krueger, Whitney S. ; Anthony, Mary S. ; Saltus, Catherine W....
Drugs - Real World Outcomes.  4 (2017)  3 - p. 139-149 , 2017
Link: https://doi.org/10.1007/..
 
?
12

Safety of Ocrelizumab in Multiple Sclerosis: Updated Analys..:

Kappos, Ludwig ; Hauser, Stephen ; Montalban, Xavier...
Neurology.  88 (2017)  16_supplement - p. , 2017
Link: https://doi.org/10.1212/..
 
?
13

Cumulative oral corticosteroid use increases risk of glucoc..:

Wormser, David ; Chen, Diana M. ; Brunetta, Paul G....
Journal of the American Academy of Dermatology.  77 (2017)  2 - p. 379-381 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Cardiovascular disease risk by assigned treatment using the..:

Stevens, June ; Erber-Oakkar, Eva ; Cui, Zhaohui...
Obesity.  24 (2016)  7 - p. 1554-1560 , 2016
Link: https://doi.org/10.1002/..
 
?
15

Body-mass index and all-cause mortality: individual-partici..:

Di Angelantonio, Emanuele ; Bhupathiraju, Shilpa N ; Wormser, David...
The Lancet.  388 (2016)  10046 - p. 776-786 , 2016
Link: https://doi.org/10.1016/..
 
1-15